Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L-Reference-Cited by-同舟云学术

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Published:2021-11-07 Issue:1 Volume:113 Page:221-228
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Sakata Shinya¹,Otsubo Kohei²^ORCID,Yoshida Hisako³,Ito Kentaro⁴^ORCID,Nakamura Atsushi⁵,Teraoka Shunsuke⁶,Matsumoto Naohisa⁷,Shiraishi Yoshimasa⁸,Haratani Koji⁹^ORCID,Tamiya Motohiro¹⁰,Ikeda Satoshi¹¹,Miura Satoru¹²^ORCID,Tanizaki Junko⁹,Omori Shota¹³,Yoshioka Hiroshige¹⁴^ORCID,Hata Akito¹⁵,Yamamoto Nobuyuki⁶,Nakagawa Kazuhiko⁹

Affiliation:

1. Department of Respiratory Medicine Kumamoto University Hospital Kumamoto Japan

2. Department of Respiratory Medicine Kitakyushu Municipal Medical Center Kitakyushu, Fukuoka Japan

3. Department of Medical Statistics Osaka City University Graduate School of Medicine Osaka Japan

4. Respiratory Center Matsusaka Municipal Hospital Matsusaka, Mie Japan

5. Department of Pulmonary Medicine Sendai Kousei Hospital Sendai, Miyagi Japan

6. Internal Medicine III Wakayama Medical University Wakayama Japan

7. Department of Respiratory Medicine Juntendo University Tokyo Japan

8. Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University Fukuoka Japan

9. Department of Medical Oncology Faculty of Medicine Kindai University Osaka‐Sayama, Osaka Japan

10. Thoracic Oncology Osaka International Cancer Institute Osaka Japan

11. Department of Respiratory Medicine Kanagawa Cardiovascular and Respiratory Center Yokohama, Kanagawa Japan

12. Department of Internal Medicine Niigata Cancer Center Hospital Niigata Japan

13. Division of Thoracic Oncology Shizuoka Cancer Center Shizuoka Japan

14. Department of Thoracic Oncology Kansai Medical University Hospital Hirakata, Osaka Japan

15. Department of Medical Oncology Kobe Minimally Invasive Cancer Center Kobe, Hyogo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15176

Reference13 articles.

1. Global cancer statistics

2. Chemotherapy of stage IIIB and IV non-small-cell lung cancer

3. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

4. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

5. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions;Scientific Reports;2024-01-18

2. Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”;Thoracic Cancer;2024-01-10

3. Pan-cancer analysis revealing the multidimensional expression and prognostic and immunologic roles of TGFB1 in cancer;Journal of International Medical Research;2024-01

4. Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study;BMC Pulmonary Medicine;2023-12-01

5. Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single‐plex testing: WJOG13620L;Cancer Medicine;2023-11-10